Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease

摘要

The invention relates to an in vitro method for determining the risk of developing thrombosis in a subject, and to an in vitro method for determining sensitivity of a subject toward a thienopyridine therapy. Both methods involve identifying a particular haplotype of the P2Y12 receptor gene.